Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Front Chem
2021 Jan 01;9:753990. doi: 10.3389/fchem.2021.753990.
Show Gene links
Show Anatomy links
Bile Acids Gate Dopamine Transporter Mediated Currents.
Romanazzi T
,
Zanella D
,
Cheng MH
,
Smith B
,
Carter AM
,
Galli A
,
Bahar I
,
Bossi E
.
???displayArticle.abstract???
Bile acids (BAs) are molecules derived from cholesterol that are involved in dietary fat absorption. New evidence supports an additional role for BAs as regulators of brain function. Sterols such as cholesterol interact with monoamine transporters, including the dopamine (DA) transporter (DAT) which plays a key role in DA neurotransmission and reward. This study explores the interactions of the BA, obeticholic acid (OCA), with DAT and characterizes the regulation of DAT activity via both electrophysiology and molecular modeling. We expressed murine DAT (mDAT) in Xenopus laevis oocytes and confirmed its functionality. Next, we showed that OCA promotes a DAT-mediated inward current that is Na+-dependent and not regulated by intracellular calcium. The current induced by OCA was transient in nature, returning to baseline in the continued presence of the BA. OCA also transiently blocked the DAT-mediated Li+-leak current, a feature that parallels DA action and indicates direct binding to the transporter in the absence of Na+. Interestingly, OCA did not alter DA affinity nor the ability of DA to promote a DAT-mediated inward current, suggesting that the interaction of OCA with the transporter is non-competitive, regarding DA. Docking simulations performed for investigating the molecular mechanism of OCA action on DAT activity revealed two potential binding sites. First, in the absence of DA, OCA binds DAT through interactions with D421, a residue normally involved in coordinating the binding of the Na+ ion to the Na2 binding site (Borre et al., J. Biol. Chem., 2014, 289, 25764-25773; Cheng and Bahar, Structure, 2015, 23, 2171-2181). Furthermore, we uncover a separate binding site for OCA on DAT, of equal potential functional impact, that is coordinated by the DAT residues R445 and D436. Binding to that site may stabilize the inward-facing (IF) open state by preventing the re-formation of the IF-gating salt bridges, R60-D436 and R445-E428, that are required for DA transport. This study suggests that BAs may represent novel pharmacological tools to regulate DAT function, and possibly, associated behaviors.
Adkins,
Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching.
2007, Pubmed
Adkins,
Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching.
2007,
Pubmed
Aggarwal,
Functional Characterization of the Dopaminergic Psychostimulant Sydnocarb as an Allosteric Modulator of the Human Dopamine Transporter.
2021,
Pubmed
Aguilar,
Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia.
2021,
Pubmed
Andrini,
The leak mode of type II Na(+)-P(i) cotransporters.
2008,
Pubmed
,
Xenbase
Belovich,
A network of phosphatidylinositol (4,5)-bisphosphate (PIP2) binding sites on the dopamine transporter regulates amphetamine behavior in Drosophila Melanogaster.
2021,
Pubmed
Bensalem,
Bile acid receptor TGR5 is critically involved in preference for dietary lipids and obesity.
2020,
Pubmed
Bhargava,
Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation.
2020,
Pubmed
Borre,
The second sodium site in the dopamine transporter controls cation permeation and is regulated by chloride.
2014,
Pubmed
,
Xenbase
Bossi,
Ion binding and permeation through the lepidopteran amino acid transporter KAAT1 expressed in Xenopus oocytes.
1999,
Pubmed
,
Xenbase
Bossi,
Exogenous protein expression in Xenopus oocytes: basic procedures.
2007,
Pubmed
,
Xenbase
Bulling,
The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters.
2012,
Pubmed
,
Xenbase
Butchbach,
Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function.
2004,
Pubmed
Chang,
Visualization of lipid raft membrane compartmentalization in living RN46A neuronal cells using single quantum dot tracking.
2012,
Pubmed
Chaudhari,
Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects.
2021,
Pubmed
Cheng,
Molecular Mechanism of Dopamine Transport by Human Dopamine Transporter.
2015,
Pubmed
Cheng,
Monoamine transporters: structure, intrinsic dynamics and allosteric regulation.
2019,
Pubmed
Cheng,
Insights into the Modulation of Dopamine Transporter Function by Amphetamine, Orphenadrine, and Cocaine Binding.
2015,
Pubmed
Cheng,
Quantitative Assessment of the Energetics of Dopamine Translocation by Human Dopamine Transporter.
2018,
Pubmed
Coleman,
X-ray structures and mechanism of the human serotonin transporter.
2016,
Pubmed
Coleman,
Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport.
2019,
Pubmed
Cortes,
Physiological and pathological implications of cholesterol.
2014,
Pubmed
Cremona,
Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT.
2011,
Pubmed
Cruz-Ramón,
Bile Acids in Nonalcoholic Fatty Liver Disease: New Concepts and therapeutic advances.
2017,
Pubmed
Erreger,
Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function.
2008,
Pubmed
Fiorucci,
Bile acids and their receptors in metabolic disorders.
2021,
Pubmed
Flynn,
Metabolic Effects of Bile Acids: Potential Role in Bariatric Surgery.
2019,
Pubmed
Foster,
Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol.
2008,
Pubmed
Giros,
Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.
1992,
Pubmed
Hao,
Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis.
2017,
Pubmed
Higashi,
Unconjugated bile acids in rat brain: Analytical method based on LC/ESI-MS/MS with chemical derivatization and estimation of their origin by comparison to serum levels.
2017,
Pubmed
Hong,
Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding.
2010,
Pubmed
Huang,
Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior.
2015,
Pubmed
Huang,
From dried bear bile to molecular investigation: A systematic review of the effect of bile acids on cell apoptosis, oxidative stress and inflammation in the brain, across pre-clinical models of neurological, neurodegenerative and neuropsychiatric disorders.
2022,
Pubmed
Ingram,
Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons.
2002,
Pubmed
Irwin,
ZINC--a free database of commercially available compounds for virtual screening.
2005,
Pubmed
Jacobs,
Ibogaine, a noncompetitive inhibitor of serotonin transport, acts by stabilizing the cytoplasm-facing state of the transporter.
2007,
Pubmed
James-Zorn,
Navigating Xenbase: An Integrated Xenopus Genomics and Gene Expression Database.
2018,
Pubmed
,
Xenbase
Jin,
INT-777 prevents cognitive impairment by activating Takeda G protein-coupled receptor 5 (TGR5) and attenuating neuroinflammation via cAMP/ PKA/ CREB signaling axis in a rat model of sepsis.
2021,
Pubmed
Jones,
Importance of cholesterol in dopamine transporter function.
2012,
Pubmed
Kawamata,
A G protein-coupled receptor responsive to bile acids.
2003,
Pubmed
Keitel,
The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain.
2010,
Pubmed
Kiriyama,
The Biosynthesis, Signaling, and Neurological Functions of Bile Acids.
2019,
Pubmed
Lester,
Permeation properties of neurotransmitter transporters.
1994,
Pubmed
Li,
Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease.
2020,
Pubmed
Lieu,
The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice.
2014,
Pubmed
,
Xenbase
Magnani,
Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin.
2004,
Pubmed
Mano,
Presence of protein-bound unconjugated bile acids in the cytoplasmic fraction of rat brain.
2004,
Pubmed
Maruyama,
Identification of membrane-type receptor for bile acids (M-BAR).
2002,
Pubmed
McMillin,
Effects of bile acids on neurological function and disease.
2016,
Pubmed
Mertens,
Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System.
2017,
Pubmed
Morris,
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.
2009,
Pubmed
Penmatsa,
X-ray structure of dopamine transporter elucidates antidepressant mechanism.
2013,
Pubmed
Perino,
Central anorexigenic actions of bile acids are mediated by TGR5.
2021,
Pubmed
Raufman,
Selective interaction of bile acids with muscarinic receptors: a case of molecular mimicry.
2002,
Pubmed
Reddy,
Bile diversion, a bariatric surgery, and bile acid signaling reduce central cocaine reward.
2018,
Pubmed
Roda,
Semisynthetic bile acid FXR and TGR5 agonists: physicochemical properties, pharmacokinetics, and metabolism in the rat.
2014,
Pubmed
Russell,
The enzymes, regulation, and genetics of bile acid synthesis.
2003,
Pubmed
Scholtz,
Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.
2014,
Pubmed
Schubring,
The bile steroid chenodeoxycholate is a potent antagonist at NMDA and GABA(A) receptors.
2012,
Pubmed
Session,
Genome evolution in the allotetraploid frog Xenopus laevis.
2016,
Pubmed
,
Xenbase
Sonders,
Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants.
1997,
Pubmed
,
Xenbase
Trott,
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
2010,
Pubmed
Wang,
Neurotransmitter and psychostimulant recognition by the dopamine transporter.
2015,
Pubmed
Waterhouse,
SWISS-MODEL: homology modelling of protein structures and complexes.
2018,
Pubmed
Wiemuth,
The bile acid-sensitive ion channel (BASIC), the ignored cousin of ASICs and ENaC.
2014,
Pubmed
Wishart,
DrugBank: a comprehensive resource for in silico drug discovery and exploration.
2006,
Pubmed
Wu,
Tauroursodeoxycholic acid attenuates neuronal apoptosis via the TGR5/ SIRT3 pathway after subarachnoid hemorrhage in rats.
2020,
Pubmed
Yanai,
Mapping gene expression in two Xenopus species: evolutionary constraints and developmental flexibility.
2011,
Pubmed
,
Xenbase
Zangerolamo,
The bile acid TUDCA and neurodegenerative disorders: An overview.
2021,
Pubmed
Zeppelin,
A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition.
2018,
Pubmed
